Cargando…
Inhibition of ribosome assembly factor PNO1 by CRISPR/Cas9 technique suppresses lung adenocarcinoma and Notch pathway: Clinical application
Growth is crucially controlled by the functional ribosomes available in cells. To meet the enhanced energy demand, cancer cells re‐wire and increase their ribosome biogenesis. The RNA‐binding protein PNO1, a ribosome assembly factor, plays an essential role in ribosome biogenesis. The purpose of thi...
Autores principales: | Roy, Sanjit K., Srivastava, Shivam, Hancock, Andrew, Shrivastava, Anju, Morvant, Jason, Shankar, Sharmila, Srivastava, Rakesh K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9889701/ https://www.ncbi.nlm.nih.gov/pubmed/36625087 http://dx.doi.org/10.1111/jcmm.17657 |
Ejemplares similares
-
SATB2 is a novel biomarker and therapeutic target for cancer
por: Roy, Sanjit K., et al.
Publicado: (2020) -
Association of Diabetes Mellitus and Alcohol Abuse with Cancer: Molecular Mechanisms and Clinical Significance
por: Lam, Bao Q., et al.
Publicado: (2021) -
Assessment of risk factors, and racial and ethnic differences in hepatocellular carcinoma
por: Thylur, Ramesh P, et al.
Publicado: (2020) -
Riluzole regulates pancreatic cancer cell metabolism by suppressing the Wnt-β-catenin pathway
por: Roy, Sanjit K., et al.
Publicado: (2022) -
Ribosome assembly factor PNO1 is associated with progression and promotes tumorigenesis in triple-negative breast cancer
por: Li, Jie, et al.
Publicado: (2022)